BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15879353)

  • 1. Debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogues.
    Wass J
    Eur J Endocrinol; 2005 May; 152(5):693-4. PubMed ID: 15879353
    [No Abstract]   [Full Text] [Related]  

  • 2. Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.
    Petrossians P; Borges-Martins L; Espinoza C; Daly A; Betea D; Valdes-Socin H; Stevenaert A; Chanson P; Beckers A
    Eur J Endocrinol; 2005 Jan; 152(1):61-6. PubMed ID: 15762188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of somatostatin analogs on tumor shrinkage in acromegaly.
    Pedroncelli AM; Montini M; Albizzi M; Barbò R; Pagani G
    J Endocrinol Invest; 2003; 26(8 Suppl):50-4. PubMed ID: 15233213
    [No Abstract]   [Full Text] [Related]  

  • 4. Rationale of pre-surgical medical treatment with somatostatin analogs in acromegaly.
    Cappabianca P; Cavallo LM; Esposito F; Romano I; Colao A; de Divitiis E
    J Endocrinol Invest; 2003; 26(8 Suppl):55-8. PubMed ID: 15233214
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of somatostatin analogs on biochemical parameters in acromegaly.
    Liuzzi A; Marzullo P
    J Endocrinol Invest; 2003; 26(8 Suppl):46-9. PubMed ID: 15233212
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment algorithm of acromegaly.
    Colao A; Pivonello R; Cappabianca P; Vitale G; Lombardi G
    J Endocrinol Invest; 2003; 26(8 Suppl):39-45. PubMed ID: 15233211
    [No Abstract]   [Full Text] [Related]  

  • 7. An evaluation of the effects of somatostatin analogue therapy in non-functioning pituitary adenomas in comparison to acromegaly.
    Zawada NB; Kunert-Radek J; Pawlikowski M; Pisarek H; Radek M
    Endokrynol Pol; 2016; 67(3):292-8. PubMed ID: 27345147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Outcome of somatostatin analogue treatment in acromegaly].
    Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
    Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodality treatment of pituitary adenomas.
    Oyesiku NM
    Clin Neurosurg; 2005; 52():234-42. PubMed ID: 16626076
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly.
    Ben-Shlomo A; Melmed S
    J Clin Endocrinol Metab; 2003 Mar; 88(3):963-8. PubMed ID: 12629068
    [No Abstract]   [Full Text] [Related]  

  • 11. Surgical-pharmacological interactions in the treatment of acromegaly.
    Abreu C; Guinto G; Mercado M
    Expert Rev Endocrinol Metab; 2019 Jan; 14(1):35-42. PubMed ID: 30595057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up results of multimodal treatment with initial surgical approach for acromegaly in a single center.
    Van Rompaey K; Unuane D; Moens M; Duerinck J; Poppe K; Velkeniers B; D'Haens J
    Acta Neurol Belg; 2013 Mar; 113(1):49-54. PubMed ID: 22975835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative use of somatostatin analogs and mortality in patients with acromegaly.
    Postma MR; Wolters TLC; van den Berg G; van Herwaarden AE; Muller Kobold AC; Sluiter WJ; Wagenmakers MA; van den Bergh ACM; Wolffenbuttel BHR; Hermus ARMM; Netea-Maier RT; van Beek AP
    Eur J Endocrinol; 2019 Jan; 180(1):1-9. PubMed ID: 30400068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presurgical treatment with somatostatin analogs in patients with acromegaly: effects on the remission and complication rates.
    Losa M; Mortini P; Urbaz L; Ribotto P; Castrignanó T; Giovanelli M
    J Neurosurg; 2006 Jun; 104(6):899-906. PubMed ID: 16776333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective treatment of recurrent acromegaly with a long-active somatostatin analogue (sandostatin).
    Miranda R; Zárate A; Ruíz Velasco G
    Arch Invest Med (Mex); 1988; 19(4):445-8. PubMed ID: 3245759
    [No Abstract]   [Full Text] [Related]  

  • 16. Pituitary gangliocytoma-adenoma presenting with acromegaly: response to treatment.
    Luna V; Morales F; Luengo LM; Sanz A; Diaz J
    Arch Intern Med; 2001 Apr; 161(7):1010-1. PubMed ID: 11295968
    [No Abstract]   [Full Text] [Related]  

  • 17. The importance of presurgical somatostatin analogue therapy in acromegaly.
    Colao A
    Endokrynol Pol; 2007; 58(4):356-60. PubMed ID: 18058729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations.
    Ludecke DK; Abe T
    Neuroendocrinology; 2006; 83(3-4):230-9. PubMed ID: 17047388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on treatment strategies for acromegaly.
    Katznelson L
    Expert Opin Pharmacother; 2008 Sep; 9(13):2273-80. PubMed ID: 18710352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the medical and surgical treatment of pituitary adenomas: the role of long-acting somatostatin analogs. Participants of the "Conference on Medical and Surgical Treatment of Pituitary Adenomas" (Zürich, 5th October, 1991).
    Fahlbusch R; Giovanelli M; Buchfelder M; Losa M
    J Endocrinol Invest; 1993 Jun; 16(6):449-60. PubMed ID: 8370920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.